VPS13A p.Glu1548Lys

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_033305.3(VPS13A):​c.4642G>A​(p.Glu1548Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00249 in 1,608,202 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E1548E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0021 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 12 hom. )

Consequence

VPS13A
NM_033305.3 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.0870

Publications

7 publications found
Variant links:
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
VPS13A Gene-Disease associations (from GenCC):
  • chorea-acanthocytosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033305.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038916469).
BP6
Variant 9-77316185-G-A is Benign according to our data. Variant chr9-77316185-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 448863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00211 (320/151702) while in subpopulation AMR AF = 0.00355 (54/15220). AF 95% confidence interval is 0.00281. There are 2 homozygotes in GnomAd4. There are 148 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033305.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
NM_033305.3
MANE Select
c.4642G>Ap.Glu1548Lys
missense
Exon 39 of 72NP_150648.2Q96RL7-1
VPS13A
NM_001018037.2
c.4525G>Ap.Glu1509Lys
missense
Exon 38 of 71NP_001018047.1Q96RL7-3
VPS13A
NM_015186.4
c.4642G>Ap.Glu1548Lys
missense
Exon 39 of 69NP_056001.1Q96RL7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
ENST00000360280.8
TSL:1 MANE Select
c.4642G>Ap.Glu1548Lys
missense
Exon 39 of 72ENSP00000353422.3Q96RL7-1
VPS13A
ENST00000376636.7
TSL:1
c.4525G>Ap.Glu1509Lys
missense
Exon 38 of 71ENSP00000365823.3Q96RL7-3
VPS13A
ENST00000643348.1
c.4642G>Ap.Glu1548Lys
missense
Exon 39 of 69ENSP00000493592.1Q96RL7-2

Frequencies

GnomAD3 genomes
AF:
0.00211
AC:
320
AN:
151584
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000436
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00355
Gnomad ASJ
AF:
0.00606
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000417
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00315
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.00206
AC:
514
AN:
249830
AF XY:
0.00216
show subpopulations
Gnomad AFR exome
AF:
0.000622
Gnomad AMR exome
AF:
0.00157
Gnomad ASJ exome
AF:
0.00508
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00322
Gnomad OTH exome
AF:
0.00411
GnomAD4 exome
AF:
0.00253
AC:
3687
AN:
1456500
Hom.:
12
Cov.:
30
AF XY:
0.00247
AC XY:
1791
AN XY:
724712
show subpopulations
African (AFR)
AF:
0.000510
AC:
17
AN:
33324
American (AMR)
AF:
0.00173
AC:
77
AN:
44626
Ashkenazi Jewish (ASJ)
AF:
0.00480
AC:
125
AN:
26056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39568
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
85968
European-Finnish (FIN)
AF:
0.000319
AC:
17
AN:
53250
Middle Eastern (MID)
AF:
0.00610
AC:
35
AN:
5734
European-Non Finnish (NFE)
AF:
0.00289
AC:
3204
AN:
1107802
Other (OTH)
AF:
0.00322
AC:
194
AN:
60172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
164
329
493
658
822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00211
AC:
320
AN:
151702
Hom.:
2
Cov.:
32
AF XY:
0.00200
AC XY:
148
AN XY:
74120
show subpopulations
African (AFR)
AF:
0.000435
AC:
18
AN:
41420
American (AMR)
AF:
0.00355
AC:
54
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00606
AC:
21
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000418
AC:
2
AN:
4788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10500
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00316
AC:
214
AN:
67826
Other (OTH)
AF:
0.00380
AC:
8
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00272
Hom.:
4
Bravo
AF:
0.00214
EpiCase
AF:
0.00306
EpiControl
AF:
0.00350

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
3
Chorea-acanthocytosis (3)
-
-
2
not specified (2)
-
-
1
VPS13A-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
9.8
DANN
Benign
0.78
DEOGEN2
Benign
0.18
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.096
N
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.0074
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.087
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.045
Sift
Benign
0.44
T
Sift4G
Benign
0.56
T
Varity_R
0.084
gMVP
0.30
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41289967;
hg19: chr9-79931101;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.